ReviewDiagnostics (Basel, Switzerland)2026
Understanding the Complexity of Sleep Disturbances in ASD: From Mechanisms to Management.
Review in Diagnostics (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Sleep disturbances represent one of the most frequent and clinically significant comorbidities in children with autism spectrum disorder (ASD), affecting approximately 50-80% of individuals. Clinically, these disturbances encompass a broad spectrum of disorders, including insomnia, parasomnias, sleep-related movement disorders, and sleep-related breathing disorders, commonly presenting with prolonged sleep latency, frequent nocturnal awakenings, reduced total sleep time, and alterations in sleep architecture. Circadian rhythm dysregulation, abnormalities in neurotransmitter systems such as GABA and serotonin, and altered melatonin signaling have been consistently implicated. These processes may reflect underlying genetic and metabolic influences affecting circadian clock regulation and synaptic function. The management of sleep disturbances in ASD requires a comprehensive approach combining behavioral strategies, caregiver education, and sleep hygiene interventions, while pharmacological options, particularly melatonin, may be considered when non-pharmacological measures are insufficient. Understanding the multifactorial mechanisms underlying sleep disturbances in ASD is essential for improving early recognition and developing individualized therapeutic strategies. This review synthesizes current evidence on the prevalence, biological mechanisms, clinical manifestations, and management of sleep disturbances in ASD, providing an integrated perspective for both clinicians and researchers.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.